Christian Schuetz, University of British Columbia
Associate Professor
Psychiatry
Vancouver, British Columbia
schutzc@interchange.ubc.ca
Office:
(778) 886-8745
Bio/Research
Dr. Schьtz is a psychiatrist with a training and research background in epidemiology as well as pre-clinical and clinical pharmacology. He studied his discipline in Vienna, Austria; Freiburg, Germany; and at Johns Hopkins University in Baltimore, USA. Complementing his clinical training was a F...
Click to Expand >>
Click to Expand >>
Bio/Research
Dr. Schьtz is a psychiatrist with a training and research background in epidemiology as well as pre-clinical and clinical pharmacology. He studied his discipline in Vienna, Austria; Freiburg, Germany; and at Johns Hopkins University in Baltimore, USA. Complementing his clinical training was a Fogarty Fellowship at the Intramural Research Center at the National Insitute of Drug Abuse/National Institute of Health (USA).
His psychiatric residency at Munich University in Germany was followed by a short fellowship in clinical neuroscience at Yale University in the USA. Before joining the Faculty of Medicine in May 2008, he was also Oberarzt (attending physician and lecturer) in the Department of Psychiatry at the University of Bonn in Germany. His responsibilities included patient care, teaching, and research.
His studies on risk factors for the development of substance dependence and relapse were funded by DFG (German Research Society), BMBF (German Ministry of Education and Research), and NIDA/NIH (US National Institute of Drug Abuse) and others.
He recently focused his efforts on: predicting treatment outcome and relapse, combining neuroimaging, neurocognition and genetic approaches with clinical and psychosocial measures.
Click to Shrink <<
His psychiatric residency at Munich University in Germany was followed by a short fellowship in clinical neuroscience at Yale University in the USA. Before joining the Faculty of Medicine in May 2008, he was also Oberarzt (attending physician and lecturer) in the Department of Psychiatry at the University of Bonn in Germany. His responsibilities included patient care, teaching, and research.
His studies on risk factors for the development of substance dependence and relapse were funded by DFG (German Research Society), BMBF (German Ministry of Education and Research), and NIDA/NIH (US National Institute of Drug Abuse) and others.
He recently focused his efforts on: predicting treatment outcome and relapse, combining neuroimaging, neurocognition and genetic approaches with clinical and psychosocial measures.
Click to Shrink <<